Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
gamithromycin (UNII: ZE856183S0) (gamithromycin - UNII:ZE856183S0)
Merial, Inc.
gamithromycin
gamithromycin 150 mg in 1 mL
SUBCUTANEOUS
PRESCRIPTION
ZACTRAN is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle. ZACTRAN is also indicated for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica and Pasteurella multocida . As with all drugs, the use of ZACTRAN is contraindicated in animals previously found to be hypersensitive to this drug.
ZACTRAN is available in three ready-to-use bottle sizes. The 100, 250 and 500 mL bottles contain sufficient solution that will treat 10, 25 and 50 head of 550 lb (250 kg) cattle respectively.
New Animal Drug Application
ZACTRAN- GAMITHROMYCIN INJECTION, SOLUTION MERIAL, INC. ---------- ZACTRAN (GAMITHROMYCIN) NADA 141-328, Approved by FDA 150 MG/ML ANTIMICROBIAL For subcutaneous injection in beef and non-lactating dairy cattle only. Not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal. CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. READ ENTIRE BROCHURE CAREFULLY BEFORE USING THIS PRODUCT. DESCRIPTION ZACTRAN Injection for Cattle is a ready to use sterile parenteral solution containing gamithromycin, a macrolide sub-class, 7a-azalide antimicrobial. Each mL of ZACTRAN contains 150 mg of gamithromycin as the free base, 1 mg of monothioglycerol and 40 mg of succinic acid in a glycerol formal vehicle. The chemical name of gamithromycin is 1-Oxa-7-azacyclopentadecan-15-one,13-[(2,6-dideoy-3-C - methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2- ethyl-3,4,10-trihydroxy 3,5,8,10,12,14- hexamethyl- 7-propyl-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-x ylo-hexopyranosyl]oxy}-, [(2R*,3S*,4R*,5S*,8R*,10R*, 11R*,12S*,13S*,14R*)]-and the structure is shown below. INDICATIONS ZACTRAN is indicated for the treatment of bovine respiratory disease (BRD) associated with ® ® _Mannheimia haemolytica_, _Pasteurella multocida, Histophilus somni_ and _Mycoplasma bovis_ in beef and non- lactating dairy cattle. ZACTRAN is also indicated for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with _Mannheimia haemolytica_ and _Pasteurella multocida_. DOSAGE AND ADMINISTRATION Administer ZACTRAN one time as a subcutaneous injection in the neck at 6 mg/kg (2 mL/110 lb) body weight (BW). If the total dose exceeds 10 mL, divide the dose so that no more than 10 mL is administered at each injection site. BODY WEIGHT (LB) DOSE VOLUME (ML) 110 2 220 4 330 6 440 8 550 10 660 12 770 14 880 16 990 18 1100 20 Animals should be appropriately restrained to achieve the proper route of administration. Use Կարդացեք ամբողջական փաստաթուղթը